MannKind Corporation (MNKD) Reveals 2026 Growth Drivers

MannKind Corporation (NASDAQ:MNKD) is 1 of the Stocks to Buy Under $10 with High Potential. On January 8, MannKind Corporation (NASDAQ:MNKD) provided concern updates and highlighted 2026 maturation drivers.

Management noted that they closed fiscal 2025 connected a precocious enactment with grounds 4th fourth gross exceeding $100 million. Looking ahead, the institution expects to execute important regulatory milestones. Management noted that the FDA is acceptable to supply Afrezza statement updates connected January 23. The update is expected to simplify dosing for patients switching from injectable rapid-acting insulin, thereby perchance boosting adoption among adults with diabetes.

Moreover, a sBLA for Afrezza besides has a PDUFA people of May 29, 2026. Management noted that an support volition effect successful the archetypal needle-free insulin for pediatrics. Lastly, the FDA has besides expected a sNDA for the FUROSCIX ReadyFlow Autoinjector, with a July 26, 2026, PDUFA date. MannKind Corporation (NASDAQ:MNKD) believes that if approved, this volition let the transportation of an 80 mg/ml IV-equivalent diuretic dose successful nether 10 seconds.

That said, Wall Street is bullish connected the stock. Recently, connected January 13, Gregory Renza from Truist Financial reiterated a Buy standing connected the banal without disclosing immoderate terms targets. Earlier, connected January 9, Brandon Folkes from H.C. Wainwright besides reiterated a Buy standing connected the banal with a terms people of $11.

MannKind Corporation (NASDAQ:MNKD) is simply a biopharmaceutical institution that develops and commercializes innovative therapeutic devices and products that code superior unmet aesculapian needs for endocrine and orphan lung diseases. The company’s pipeline and products see Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.

While we admit the imaginable of MNKD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.